Crosslink is engineering cancer medicines that conditionally assemble in the tumor microenvironment. Our technology can be adapted to multiple therapeutic modalities, improving safety and efficacy.
Focus/Therapeutic Area:
Oncology
Stage/Status:
Seed
Website:
—